First world countries would benefit from dedicating so many resources to controlling the disease by developing a vaccine, which can help reduce the chances of malaria re-emerging in the form of Plasmodium vivax. These practices will help not only limit malaria infections, but will also help researchers find strategies to limit the spread of all insect-borne diseases. Prevention strategies for mosquito-related infections include: Vaccinations to improve people's immunity and new antimalarial drugs. Say no to plagiarism. Get a tailor-made essay on "Why Violent Video Games Shouldn't Be Banned"? Get an original essay There are significant reasons for the reemergence of malaria in Africa, Asia, and Latin America. With the rapid spread of resistance of malaria parasites to chloroquine and other quinolines, and frequent armed conflicts in many countries, forcing large populations to settle in harsh conditions and sometimes in areas of high malaria transmission. These are some of the many significant reasons for the re-emergence of malaria. The current strategy for malaria control in Africa, adopted by the Ministerial Conference on Malaria in Amsterdam in 1992, is to prevent death, reduce disease and reduce social and economic losses due to the disease. There are two main measures adopted to eliminate and reduce the incidence of malaria infestation in Africa. The first concerns drugs for the early treatment of the disease, the management of serious and complicated cases and prophylactic use on the most vulnerable population (most likely pregnant women). The second is nets treated with insecticide to protect against mosquito bites. Each tool presents its own challenges when it comes to field implementation. Despite the lower risk of malaria infection in Asia compared to many African settings, the Greater Mekong subregion faces significant challenges in maintaining its successes to date in malaria control and prevention. Resistance to artemisinin, which is the most effective treatment for malaria, poses a significant danger if not eliminated and could potentially lead to an increase in malaria cases. With the threat of resistance spreading across the region and beyond, the Malaria Consortium plays a significant role, working closely with national and international authorities and partners, to address this public health emergency. Vaccinations use vaccines to develop immunity and form a memory response to the pathogenic bodies into thinking that we have already had the disease. A vaccine contains a dead or weakened virus that our body can easily fight off. Memory cells are a type of B lymphocyte, capable of remembering a virus for the next time the body is infected. Antibodies, also called immunoglobulins, are Y-shaped molecules that are proteins produced by the body to help fight foreign substances called antigens. Antigens are a substance, such as bacteria, viruses, or fungi, that can cause infection or disease and stimulate the immune system to produce antibodies. Immunization may provide greater benefit if enough people are vaccinated to help stop the spread of bacteria and fungi. Disease-causing viruses. Individuals with AIDS, cancer, or transplant patients are at increased risk of severe disease because they have immunocompromised or weakened immune systems. This may vary depending on each person's degree of immune suppression. Prevention of various diseases.